Bicara Therapeutics (BCAX) Shares Outstanding (Entity) (2023 - 2026)

Bicara Therapeutics (BCAX) Shares Outstanding (Entity) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 Bicara Therapeutics 1.60 Bn 1.60 Bn - 65.93 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 65.93 Mn
Mar 31, 2026 65.55 Mn
Dec 31, 2025 54.68 Bn
Sep 30, 2025 54.61 Mn
Jun 30, 2025 54.56 Mn
Mar 31, 2025 54.53 Mn
Dec 31, 2024 16.81 Bn
Sep 30, 2024 10.90 Mn
Jun 30, 2024 1.02 Mn
Mar 31, 2024 640,386.00
Dec 31, 2023 580.11 Mn
Sep 30, 2023 579,975.00